Practical Pharmacology - Module 1, Session 3
Ethics in Pediatric Clinical Pharmacology - Module 1, Session 5
Drug Absorption and Bioavailability - Module 2, Session 1
Ethics in Adult Clinical Pharmacology - Module 1 Session 6
Introduction to Module 2_ Pharmacokinetics with Dr. Anne Zajicek
Clinical Drug Interactions - Module 7, Session 5
Drug Development in the Pediatric Population - Module 6, Session 7
Drug Therapy in Pregnant and Nursing Women - Module 4, Session 4
Natural Products - Module 6, Session 9
FDA Approval Considerations - Module 6, Session 13
Combinatorial Drug Screening - Module 6, Session 4
T-Cell Therapies_ Principles and Practice - Module 6, Session 10
Drug Discovery - Module 6, Session 1
Post-Marketing Drug Safety Surveillance - Module 7, Session 7
Dose Modifications Based on Pharmacogenetics Research - Module 7, Session 3
Clinical Assessment of Adverse Drug Reactions - Module 7, Session 6
Pharmacokinetic & Pharmacodynamic Considerations in Development of Macromolecules - Mod 6, Ses 11
Pharmacokinetics in Patients Requiring Renal Replacement Therapy Part 2 - Module 4, Session 2
Dose Selection and Optimization in the Adult Population - Module 6, Session 6
Drug Formulation & Delivery - Module 6, Session 8
Computational Methods of Drug Discovery and Design - Module 6, Session 3 (1)
Introduction to Clinical Pharmacology and Therapeutics - Module 1, Session 1
Computational Methods of Drug Discovery and Design - Module 6, Session 3
Pharmacogenomics - Module 7, Session 2
Pharmacokinetics and Obesity - Module 4, Session 7
Biomarkers of Drug Effects - Module 5, Session 1
The Liver and Drugs - Module 4, Session 3
Introduction to Pharmacology, Drug Development and Clinical Pharmacology - Module 1, Session 2
Compartmental Analysis of Drug Distribution - Module 2, Session 3
Animal Scale Up and First-in-Human Studies - Module 6, Session 5
Immunotherapeutics - Module 5, Session 5
Developmental and Pediatric Pharmacology - Module 4, Session 5
Design of Clinical Drug Development Programs - Module 6, Session 12
Biochemical Mechanisms of Drug Toxicity - Module 1, Session 4
Pharmacometabolomics_ Implications for Clinical Pharmacology - Module 7, Session 1
Pathways of Drug Metabolism - Module 3, Session 1
Pharmacodynamic and Pharmacokinetic Modeling of Data - Module 5, Session 2
Population Pharmacokinetics - Module 2, Session 5
Drug Transport Across the Blood Brain Barrier - Module 3, Session 6
Chemical Analysis of Drugs and Metabolites - Module 2, Session 6
Quality Assurance For Drug Therapy - Module 7, Session 8
Quantitative Systems Pharmacology - Module 6, Session 2
Use of Positron Emission Tomography (PET) in Pharmacokinetics - Module 2, Session 2
P-Glycoprotein and Drug Transport Part 1 - Module 3, Session 3
Drug Transporters in ADME and Drug Action - Module 3, Session 2
Drug Therapy in the Geriatric Population - Module 4, Session 6
Noncompartmental vs. Compartmental Approaches to Pharmacokinetic Analysis - Module 2, Session 4
Clinical Pharmacogenomics Testing - Module 7, Session 4
Membrane Transport - Module 3, Session 5
